Partners & Network
Welcome to News & Insights
I accept terms & conditions
Thanks for submitting!
Original Posts & Published Articles
The Second Wave of Biosimilars. How to find the best ones?
Biosimilars to increase adoption of biologics in Emerging Markets. Past Evidence for the Future.
Tenders and long term sustainability of biosimilars in Europe.
At least 255 pharmaceuticals playing biosimilars. Rise of the "Pharmerging" middle class.
Why biosimilars are an opportunity but could also be a trap.
Is it true that biosimilars will increase the use of the molecule? Not always.
The Second Wave Of Biosimilars: New Scenarios, New Rules
How Will COVID-19 Impact Biosimilar Trends In The Top 5 European Markets?
EU5 Biosimilar Adoption: What Can The Past Tell Us About The Future?